TP53 and neoplasm: However, we recently reported that hypoxic-induced HIPK2 inhibition can be completely restored by zinc supplementation that reactivates p53 apoptotic response to drug [40], hypothesizing that HIPK2 gene or protein inactivation can make a big difference in rescuing p53 activity and therefore tumor response to drug in terms of therapeutical strategies.